The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices today recommended Pfizer’s COVID-19 vaccine for administration in adolescents ages 12 to 15. The 14-0 vote, with one recusal, clears an important hurdle for the vaccine to be administered to that age group immediately. CDC’s director must now decide whether to accept the committee’s recommendation.
 
During the meeting, the CDC said it will no longer recommend that COVID-19 vaccines be administered alone, forgoing its previous suggestion of a minimum interval of 14 days before or after administration of another vaccine. CDC, while acknowledging that there is insufficient data available on the simultaneous administration of COVID-19 vaccines with other vaccines, said the previous policy was established out of an abundance of caution, and extensive experience with non-COVID-19 vaccines provides the necessary basis for this shift. The agency’s hope is that the changed recommendation will enable pediatricians to administer COVID-19 vaccines in conjunction with patients’ other scheduled vaccinations that may have been missed due to the pandemic. 

Related News Articles

Headline
The Health Resources and Services Administration today awarded 14 organizations grants to hire people to support COVID-19 vaccination and outreach in…
Headline
The Food and Drug Administration Friday authorized for emergency use two batches of drug substance manufactured for the Janssen (Johnson & Johnson)…
Headline
Novavax today announced phase 3 trial results for its COVID-19 vaccine, saying it provides 100% protection against moderate and severe disease, with a 90.…
Headline
The Food and Drug Administration yesterday warned health care providers and the public not to use an antigen test for COVID-19 made by Innova Medical Group and…
Headline
The Centers for Disease Control and Prevention is asking jurisdictions to distribute portions of their COVID-19 vaccine allocations to enable administration at…
Headline
Johnson & Johnson today said the Food and Drug Administration agreed to extend the expiration date for its COVID-19 vaccine by six weeks. The move means…